Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON42198Active, not recruiting
Open-label trial of capsaicin (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Baseline impedance after capsaicin versus control infusion. Started Nov 2015; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON42198.